Publications by authors named "Gerhard Ehninger"

Claim this Profile
H
Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo-Controlled Phase 2 DELTA Trial.
Katja Sockel, Christoph Röllig, Anke Mütherig, Martina Crysandt, Sven Zukunft, Gerhard Ehninger

Am J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial.
Anne Sophie Platzbecker, Julia Annabell Georgi, Jan Moritz Middeke, Katja Sockel, Rebekka Wehner, Gerhard Ehninger

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial.
Matthias Stelljes, Jan Moritz Middeke, Gesine Bug, Eva-Maria Wagner-Drouet, Lutz P Müller, Gerhard Ehninger

Blood· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial.
Uwe Platzbecker, Lionel Adès, Pau Montesinos, Emanuele Ammatuna, Pierre Fenaux, Gerhard Ehninger

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML.
Sebastian Stasik, Jan-Niklas Eckardt, Christoph Röllig, Claudia D Baldus, Uwe Platzbecker, Gerhard Ehninger

Br J Haematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia.
Christoph Röllig, Björn Steffen, Christoph Schliemann, Jan-Henrik Mikesch, Nael Alakel, Gerhard Ehninger

J Clin Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[ePROs in the routine care of a major oncology center: Results and experiences].
Martin Eichler, Leopold Hentschel, Beate Hornemann, Markus Schuler, Stephan Richter, Gerhard Ehninger

Z Evid Fortbild Qual Gesundhwes· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens.
David Baden, Sven Zukunft, Gema Hernandez, Nadine Wolgast, Sophie Steinhauser, Gerhard Ehninger

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.
Matthias Stelljes, Jan Moritz Middeke, Gesine Bug, Eva-Maria Wagner-Drouet, Lutz P Müller, Gerhard Ehninger

Lancet Haematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of CEBPA mutational subgroups in adult AML.
Julia-Annabell Georgi, Sebastian Stasik, Michael Kramer, Manja Meggendorfer, Christoph Röllig, Gerhard Ehninger

Leukemia· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia.
Jan-Niklas Eckardt, Sebastian Stasik, Christoph Röllig, Andreas Petzold, Tim Sauer, Gerhard Ehninger

Leukemia· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and and/or - ITD mutations: results of the SAL MIDOKIT trial.
Leo Ruhnke, Christoph Röllig, Sylvia Herold, Tim Sauer, Christian H Brandts, Gerhard Ehninger

Haematologica· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome.
Julia-Annabell Georgi, Sebastian Stasik, Jan-Niklas Eckardt, Sven Zukunft, Marita Hartwig, Gerhard Ehninger

Blood Cancer J· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia: A Randomized Clinical Trial.
Martin Bornhäuser, Christoph Schliemann, Johannes Schetelig, Christoph Röllig, Michael Kramer, Gerhard Ehninger

JAMA Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow‑up of 14.4 years.
Sabine Kürzel, André-René Blaudszun, Lilly Stahl, Regina Herbst, Frank Kroschinsky, Gerhard Ehninger

J Cancer Res Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial.
Nikolaus Jahn, Ekaterina Jahn, Maral Saadati, Lars Bullinger, Richard A Larson, Gerhard Ehninger

Leukemia· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation.
Desiree Kunadt, Sebastian Stasik, Klaus H Metzeler, Christoph Röllig, Christoph Schliemann, Gerhard Ehninger

J Hematol Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML.
Sebastian Stasik, Clara Burkhard-Meier, Michael Kramer, Jan M Middeke, Uta Oelschlaegel, Gerhard Ehninger

Blood Adv· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMT.
Edouard Forcade, Sylvie Chevret, Jürgen Finke, Gerhard Ehninger, Francis Ayuk

Bone Marrow Transplant· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT.
Rafal Machowicz, Felipe Suarez, Wieslaw Wiktor-Jedrzejczak, Diderik-Jan Eikema, Liesbeth C de Wreede, Gerhard Ehninger

Bone Marrow Transplant· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations.
Jan-Niklas Eckardt, Friedrich Stölzel, Desiree Kunadt, Christoph Röllig, Sebastian Stasik, Gerhard Ehninger

J Hematol Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen receptor T-cell therapy in acute myeloid leukemia.
Jan Koedam, Martin Wermke, Armin Ehninger, Marc Cartellieri, Gerhard Ehninger

Curr Opin Hematol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point Mutations in the -ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant -PTD.
Sebastian Stasik, Michael Kramer, Sven Zukunft, Christoph Röllig, Claudia D Baldus, Gerhard Ehninger

Front Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse.
Katja Sockel, Friedrich Stölzel, Franziska Hönl, Henning Baldauf, Christoph Röllig, Gerhard Ehninger

Cancer Manag Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal Cancer.
Sebastian Stasik, Marika Mende, Caroline Schuster, Sandra Mahler, Daniela Aust, Gerhard Ehninger

Front Genet· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis